Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) infection has a high mortality rate, making the development of novel effective antibiotic therapeutic strategies highly critical. Antimicrobial peptides can outperform conventional antibiotics regarding drug resistance and broad-...
Guardado en:
Autores principales: | Joonhyeok Choi, Ahjin Jang, Young Kyung Yoon, Yangmee Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4afe662831ee4e63ba07c0939f4ea86d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
por: Manigandan Krishnan, et al.
Publicado: (2021) -
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Adewale Oluwaseun Fadaka, et al.
Publicado: (2021) -
Antimicrobial Peptides in the Battle against Orthopedic Implant-Related Infections: A Review
por: Bruna Costa, et al.
Publicado: (2021) -
Host Defense Peptide-Mimicking Polymers and Polymeric-Brush-Tethered Host Defense Peptides: Recent Developments, Limitations, and Potential Success
por: Hashem Etayash, et al.
Publicado: (2021) -
Current Advances in Lipid and Polymeric Antimicrobial Peptide Delivery Systems and Coatings for the Prevention and Treatment of Bacterial Infections
por: Miriam E. van Gent, et al.
Publicado: (2021)